MARKSANS PHARMA LTD.
Market Cap.(`)
|
7665.26 Cr.
|
P/BV
|
4.39
|
Book Value (`)
|
38.51
|
52 Week High/Low ( ` )
|
186/71
|
FV/ML
|
1/1
|
P/E(X)
|
28.78
|
Book Closure
|
07/06/2023
|
EPS (`)
|
5.88
|
Div Yield (%)
|
0.30
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 337.65 | 247.51 | 0.00 | 157.17 | 104.31 |
| | | | | |
Net CashFlow From Operating Activities | 237.41 | 99.26 | 0.00 | 209.94 | 27.40 |
Net Cash Used In Investing Activities | -259.21 | -41.69 | 0.00 | -59.53 | -13.48 |
Net Cash Used From Financing Activities | 197.83 | 79.51 | 0.00 | -90.15 | -20.78 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 176.03 | 137.08 | 0.00 | 60.27 | -6.86 |
Cash And Cash Equivalents Begin of Year | 206.41 | 212.18 | 0.00 | 32.85 | 39.72 |
Cash And Cash Equivalents End Of Year | 382.44 | 349.27 | 0.00 | 93.12 | 32.85 |